Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan
2. Cepharanthin
1. 481-49-2
2. Cepharanthin
3. (+)-cepharanthine
4. O-methylcepharanoline
5. Cepharantin
6. Cepharanthine [jan]
7. 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan
8. Nsc-623442
9. Chebi:3546
10. 7592yj0j6t
11. Nsc623442
12. Cepharanthine (jan)
13. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
14. Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-
15. Ecaene (non-preferred Name)
16. Dsstox_cid_25957
17. Dsstox_rid_81253
18. Dsstox_gsid_45957
19. 22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
20. Cas-481-49-2
21. Ccris 6539
22. Sr-01000779734
23. Nsc 623442
24. Brn 0075231
25. Unii-7592yj0j6t
26. Cepharanthin,(s)
27. Ncgc00095194-01
28. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dod
29. Cepharanthine (tn)
30. Spectrum2_000832
31. Spectrum3_001963
32. 12-o-methylcepharanoline
33. Cepharanthine [mi]
34. Upcmld-dp054
35. Bspbio_003563
36. 4-27-00-09061 (beilstein Handbook Reference)
37. Mls000728518
38. Schembl154545
39. Spectrum1505322
40. Spbio_000783
41. Cepharanthine [who-dd]
42. Chembl449782
43. Dtxsid6045957
44. Upcmld-dp054:001
45. Kbio3_002909
46. Cepharanthine, >=95% (hplc)
47. Cepharanthine, >=98% (hplc)
48. Hms1922j12
49. Hms2232f21
50. Pharmakon1600-01505322
51. Hy-n6972
52. Tox21_111483
53. Bbl030154
54. Bdbm50423643
55. Ccg-40294
56. Mfcd00210482
57. Nsc758965
58. S4238
59. Stk801907
60. Zinc30726863
61. Akos004119865
62. Tox21_111483_1
63. Nsc-758965
64. Sdccgmls-0066893.p001
65. Ncgc00161621-01
66. Ncgc00161621-02
67. Ncgc00161621-03
68. Ncgc00161621-05
69. Ncgc00161621-13
70. Ac-15206
71. As-17451
72. Smr000445632
73. Sbi-0207049.p001
74. Cs-0007138
75. M2968
76. C09391
77. D01035
78. Ab00643356_08
79. Ab00643356_09
80. 481c492
81. A871948
82. Q-100524
83. Sr-01000779734-3
84. Sr-01000779734-4
85. Brd-k96194081-001-06-0
86. Q15410888
87. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene
88. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2??,??.1?,??.1??,??.0?,?.0??,??.0??,??]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene
| Molecular Weight | 606.7 g/mol |
|---|---|
| Molecular Formula | C37H38N2O6 |
| XLogP3 | 6.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 2 |
| Exact Mass | 606.27298694 g/mol |
| Monoisotopic Mass | 606.27298694 g/mol |
| Topological Polar Surface Area | 61.9 Ų |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 994 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Radiation-Protective Agents
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
71
PharmaCompass offers a list of Cepharanthine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cepharanthine manufacturer or Cepharanthine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cepharanthine manufacturer or Cepharanthine supplier.
PharmaCompass also assists you with knowing the Cepharanthine API Price utilized in the formulation of products. Cepharanthine API Price is not always fixed or binding as the Cepharanthine Price is obtained through a variety of data sources. The Cepharanthine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cepharanthine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cepharanthine, including repackagers and relabelers. The FDA regulates Cepharanthine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cepharanthine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cepharanthine supplier is an individual or a company that provides Cepharanthine active pharmaceutical ingredient (API) or Cepharanthine finished formulations upon request. The Cepharanthine suppliers may include Cepharanthine API manufacturers, exporters, distributors and traders.
Cepharanthine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cepharanthine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cepharanthine GMP manufacturer or Cepharanthine GMP API supplier for your needs.
A Cepharanthine CoA (Certificate of Analysis) is a formal document that attests to Cepharanthine's compliance with Cepharanthine specifications and serves as a tool for batch-level quality control.
Cepharanthine CoA mostly includes findings from lab analyses of a specific batch. For each Cepharanthine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cepharanthine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cepharanthine EP), Cepharanthine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cepharanthine USP).
